Engaging in the repeal of the Therapeutic Products Act and connections across the Pacific
As we embrace the arrival of koanga/spring, I reflect on a year that has tested our resolve and highlighted numerous challenges within our health system. The journey has been anything but easy, marked by shifting goalposts and increased demands and pressures that have weighed heavily on our resources and wellbeing. Yet, as the days grow warmer and kotukutuku and kowhai start to flower, there is a glimmer of hope for connection and collaboration. While we celebrate spring’s promise of rejuvenation, we must also confront the pressing concerns that linger within our healthcare landscape. It is more important than ever to come together, share our insights, and chart a path forward that prioritises both patient care and the wellbeing of those who provide it.
Recently, along with Graham Roper from NZNC, I met with representatives from the Ministry of Health Manatū Hauora to engage in an important dialogue regarding the recently repealed Therapeutic Products Act (TPA). As a quick refresher; this act was introduced by the previous government to replace the Medicines Act 1981 and Medicines Regulations 2003. Repealing this act was part of the government’s 100-day plan, and thus, on 6 May 2024 Cabinet agreed to the TPA Repeal Bill. This meeting provided a vital platform for us to understand the path forward, and to voice concerns and share insights about the implications of the repeal, including its potential impact on anaesthesia practices and patient safety. Manatū Hauora representatives emphasised the government’s commitment to developing a robust regulatory framework that will ensure the safe and effective use of therapeutic products in our healthcare system. As anaesthetists, we recognise the significance of being involved in these discussions. We are eager to collaborate with the Ministry as they work to create policies that not only support our profession but ultimately enhance the quality of care delivered to our patients.
We look forward to engaging with members to contribute our expertise as these plans continue to evolve.
As we look ahead to the upcoming Pacific Society of Anaesthetists meeting in the beautiful setting of Pacific Harbour, Fiji, CEO Kylie McQuellin and I are excited about the unique opportunity it brings to connect with the anaesthetic community across the Pacific region. This gathering promises to be more than just an academic exchange; it is a chance to engage in meaningful discussions about the specific challenges faced by our Pacific anaesthetist colleagues. By sharing experiences and best practices, we hope to explore innovative ways to further support and enhance anaesthesia services in the Pacific alongside our Global Health Committee.
The following week both Kylie and I will also be in Darwin at the Australian Society of Anaesthetists Conference. With a strong lineup of speakers and thought-provoking sessions, I am looking forward to many opportunities for learning and collaboration. Our relationship with the ASA is strong, and these meetings allow valuable conversations about shared challenges, whether workforce and recruitment, supply chain concerns, or upholding patient safety with appropriately skilled anaesthesia providers. As we gather in this vibrant (and hot!) city, we are excited to strengthen bonds, exchange ideas, and celebrate our shared commitment to advancing anaesthesia practice in Australasia and the Pacific. Together, these conferences promise to inspire and unite anaesthetists as we navigate the evolving landscape of our profession.
Before we know it our own Aotearoa NZ Anaesthesia ASM will be upon us in November. I am immensely proud of the mahi being done by both the organising committee at Waitematā and the teams at NZNC and NZSA alongside NZATS. This conference and accompanying social events will be exceptional – and I hope to see you there.
